Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma
Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma
Not yet recruiting · NCT07616141 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma | Neoplasms by Histologic Type, adenocarcinoma, adenoid cystic carcinoma, carcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2026-06-01 | NCT07616141 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eye & ENT Hospital of Fudan University | 64 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eye & ENT Hospital of Fudan University | Shanghai | China | 17 |
| The Affiliated Hospital of Qingdao University | Qingdao | China | 50 |
| The Third Affiliated Hospital of Sun Yat-sen University | Guangzhou | China | 22 |
| Xuanwu Hospital, Capital Medical University | Beijing | China | 37 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 7 |